The Curbsiders Internal Medicine Podcast
R.S.V. Immunization with The Cribsiders
Jan 31, 2024
Dr. Buddy Creech, Pediatric Infectious Disease at Vanderbilt, talks about RSV immunizations, including eligibility criteria and challenges in finding doses. The discussion covers the importance of RSV immunizations for all age groups, the concept of pre-fusion and post-fusion in relation to the virus's fusion protein, alternatives to Bayfortas, health equity for indigenous populations, and key takeaways such as preventing lower respiratory tract disease.
49:43
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- New RSV vaccines target the pre-fusion form of the F protein on the virus, reducing symptom severity and hospitalizations.
- RSV vaccination efforts may expand to various age groups to reduce the overall burden of disease and protect vulnerable populations.
Deep dives
RSV is a significant risk for both infants and older adults
RSV is a leading cause of medically attended respiratory tract infections in infants and older adults. The disease burden is highest in these age groups, and it is crucial to prevent RSV infections to protect both individuals and those around them.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
